Rodallec, A.
Franco, C.
Robert, S.
Sicard, G.
Giacometti, S.
Lacarelle, B.
Bouquet, F.
Savina, A.
Lacroix, R.
Dignat-George, F.
Ciccolini, J.
Poncelet, P.
Fanciullino, R.
Article History
Received: 30 September 2019
Accepted: 6 February 2020
First Online: 5 March 2020
Competing interests
: A.S. and F.B. are members of Institut Roche, a joint institute from Roche Laboratories that commercializes trastuzumab and has partly funded this study. J.C. and R.F. obtained fees as board members of Roche. C.F. and P.P. are members of Biocytex that developed the prototype IgHg calibration beads. The other authors report no conflicts of interest in this work.